84 related articles for article (PubMed ID: 26708148)
21. MEF2D overexpression contributes to the progression of osteosarcoma.
Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
[TBL] [Abstract][Full Text] [Related]
22. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
[TBL] [Abstract][Full Text] [Related]
23. Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression.
Wu J; Zhong D; Fu X; Liu Q; Kang L; Ding Z
Int J Mol Sci; 2014 Apr; 15(4):5570-81. PubMed ID: 24694542
[TBL] [Abstract][Full Text] [Related]
24. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model.
Yu X; Luo Y; Zhou Y; Zhang Q; Wang J; Wei N; Mi M; Zhu J; Wang B; Chang H; Tang Y
Int J Oncol; 2008 Sep; 33(3):555-63. PubMed ID: 18695886
[TBL] [Abstract][Full Text] [Related]
25. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
26. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
Wang Y; Fu Q; Zhao W
Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
[TBL] [Abstract][Full Text] [Related]
27. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
28. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
Zhang C; Zhao Y; Zeng B
Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
Liu W; Xu G; Liu H; Li T
FEBS Lett; 2015 Oct; 589(20 Pt B):3148-53. PubMed ID: 26341146
[TBL] [Abstract][Full Text] [Related]
30. [ShRNA of Cyclin D1 decreased the proliferation of human osteosarcoma cell line SOSP-9607.].
Ding Y; Fan DG; Shan LQ; Wang YC; Yang TT; Ma BA
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1155-7. PubMed ID: 19961806
[TBL] [Abstract][Full Text] [Related]
31. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
32. Antidifferentiation Noncoding RNA Regulates the Proliferation of Osteosarcoma Cells.
Min L; Hong S; Duan H; Zhou Y; Zhang W; Luo Y; Shi R; Tu C
Cancer Biother Radiopharm; 2016 Mar; 31(2):52-7. PubMed ID: 26986815
[TBL] [Abstract][Full Text] [Related]
33. siRNA targeting TCTP suppresses osteosarcoma cell growth and induces apoptosis in vitro and in vivo.
Shen JH; Qu CB; Chu HK; Cui MY; Wang YL; Sun YX; Song YD; Li G; Shi FJ
Biotechnol Appl Biochem; 2016; 63(1):5-14. PubMed ID: 25522670
[TBL] [Abstract][Full Text] [Related]
34. PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.
Yang SH; Sharrocks AD
Mol Cell; 2006 May; 22(4):477-87. PubMed ID: 16713578
[TBL] [Abstract][Full Text] [Related]
35. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.
Sunters A; McCluskey J; Grigoriadis AE
Dev Genet; 1998; 22(4):386-97. PubMed ID: 9664690
[TBL] [Abstract][Full Text] [Related]
36. microRNA‑25 promotes osteosarcoma cell proliferation by targeting the cell‑cycle inhibitor p27.
Wang XH; Cai P; Wang MH; Wang Z
Mol Med Rep; 2014 Aug; 10(2):855-9. PubMed ID: 24859599
[TBL] [Abstract][Full Text] [Related]
37. Decreased RECQL5 correlated with disease progression of osteosarcoma.
Wu J; Zhi L; Dai X; Cai Q; Ma W
Biochem Biophys Res Commun; 2015 Nov; 467(4):617-22. PubMed ID: 26499077
[TBL] [Abstract][Full Text] [Related]
38. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
[TBL] [Abstract][Full Text] [Related]
40. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
Park WH; Kim ES; Kim BK; Lee YY
Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]